These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11376878)

  • 1. Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria.
    Suenaga K; Kanda Y; Niiya H; Nakai K; Saito T; Saito A; Ohnishi M; Takeuchi T; Tanosaki R; Makimoto A; Miyawaki S; Ohnishi T; Kanai S; Tobinai K; Takaue Y; Mineishi S
    Exp Hematol; 2001 May; 29(5):639-42. PubMed ID: 11376878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria.
    Lee JL; Lee JH; Lee JH; Choi SJ; Kim S; Seol M; Lee YS; Chi HS; Park CJ; Kim WK; Lee JS; Lee KH
    Eur J Haematol; 2003 Aug; 71(2):114-8. PubMed ID: 12890150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.
    Shasheleva DA; Maschan AA; Shelikhova LN; Petrova UN; Kurnikova EE; Illarionova OI; Boyakova EV; Novichkova GA; Maschan MA
    Ter Arkh; 2018 Aug; 90(7):57-64. PubMed ID: 30701923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
    Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single-center study.
    Kamranzadeh Fumani H; Zokaasadi M; Kasaeian A; Alimoghaddam K; Mousavi SA; Bahar B; Vaezi M; Ghavamzadeh A
    Hematol Oncol; 2017 Dec; 35(4):935-938. PubMed ID: 27761934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
    Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Benvenuto F; Figari O; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):59-62. PubMed ID: 10629593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
    Shapira MY; Or R; Resnick IB; Bitan M; Ackerstein A; Samuel S; Elad S; Zilberman I; Miron S; Slavin S
    Bone Marrow Transplant; 2003 Sep; 32(6):557-61. PubMed ID: 12953126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical hematopoietic stem cell transplant in paroxysmal nocturnal hemoglobinuria.
    Tian H; Liu L; Chen J; Xu Y; Jin Z; Miao M; Fu Z; Qiu H; Sun A; Wu D
    Leuk Lymphoma; 2016; 57(4):835-41. PubMed ID: 26911378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
    Nagler A; Or R; Naparstek E; Varadi G; Slavin S
    Exp Hematol; 2000 Sep; 28(9):1096-104. PubMed ID: 11008023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome].
    Liu LM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Chen SN; Sun AN; Miao M; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):472-476. PubMed ID: 31340619
    [No Abstract]   [Full Text] [Related]  

  • 12. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
    Saito AM; Kami M; Mori S; Kanda Y; Suzuki R; Mineishi S; Takami A; Taniguchi S; Takemoto Y; Hara M; Yamaguchi M; Hino M; Yoshida T; Kim SW; Hori A; Ohashi Y; Takaue Y
    Am J Hematol; 2007 Oct; 82(10):873-80. PubMed ID: 17570513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
    Hegenbart U; Niederwieser D; Forman S; Holler E; Leiblein S; Johnston L; Pönisch W; Epner E; Witherspoon R; Blume K; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):689-97. PubMed ID: 14652852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group.
    Markiewicz M; Drozd-Sokolowska J; Biecek P; Dzierzak-Mietla M; Boguradzki P; Staniak M; Piatkowska-Jakubas B; Piekarska A; Tormanowska M; Halaburda K; Ussowicz M; Waszczuk-Gajda A; Basak G; Bołkun L; Rybka J; Sadus-Wojciechowska M; Giebel S; Szmigielska-Kaplon A; Mendek-Czajkowska E; Warzybok K; Burdacki A; Dwilewicz-Trojaczek J
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1833-1839. PubMed ID: 32512214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
    Oved JH; Stanley N; Babushok DV; Huang Y; Duke JL; Monos DS; Teachey DT; Olson TS
    Pediatr Transplant; 2019 Jun; 23(4):e13393. PubMed ID: 30900367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.